Boehringer Ingelheim (Canada) Ltd. and IBM Canada Announce First of its Kind Collaboration to Integrate Blockchain Technology into Clinical Trials

Blockchain technology has the potential to improve trust, transparency, patient safety and patient empowerment in clinical trials